Skip to content

Study of the effects of intrapulmonary oscillation and lung expansion techniques in patients with airway clearance disorders

Study of the effects of intrapulmonary oscillation and lung expansion techniques in patients with airway clearance disorders

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109941
Enrollment
Unknown
Registered
2025-09-28
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Those with impaired airway clearance: presence of large amounts of sputum, mucus, and other secretions

Interventions

Research group:Conventional therapy + OLE
Control group:conventional treatment

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. 18 to 80 years of age; 2. Vital signs are stable. 3. Richmond Agitation-Sedation Score (RASS score) between -2 and +1; 4. Those with impaired airway clearance: presence of large amounts of sputum, mucus, and other secretions; ineffective or inefficient cough; presence of sputum sounds on auscultation, decreased ventilation or oxygenation; and chest CT/X-rays suggesting more inflammation of the lungs or pulmonary atelectasis. 5. The patients and their families were informed and consented to the study;

Exclusion criteria

Exclusion criteria: 1. Patients with atrial fibrillation, severe heart failure, haemodynamic instability; 2. Patients with active airway bleeding, severe emphysema, alveoli, history of pneumothorax within 3 months, total lung resection, pulmonary embolism; 3. Severe spinal and thoracic deformities, unhealed rib fractures; 4. Patients with pacemaker implants; 5. Pregnant and lactating women; 6. Patients with frequent vomiting within 1 week; 7. Other reasons why the medical team felt it was not appropriate to carry out the treatment; 8. Persons who have not signed the informed consent form;

Design outcomes

Primary

MeasureTime frame
Sputum colour and character, sputum viscosity, sputum volume;Clinical Pulmonary Infection Score;EIT parameters;

Secondary

MeasureTime frame
Cough/expiratory peak flow rate;Tolerance level, safety;Blood gas analysis and oxygenation index;spirometry;Cost of antibiotic use;Semi-quantitative cough strength score;Maximum suction pressure, maximum exhalation pressure;

Countries

China

Contacts

Public ContactHuang Tao

The First Affiliated Hospital of Chongqing Medical University

470622696@qq.com+86 23 8901 1876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026